[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Re: [Gnumed-devel] Re: Drug interactions software -- significance and de
Re: [Gnumed-devel] Re: Drug interactions software -- significance and design considerations
Tue, 3 Aug 2010 22:19:28 +0200
On Tue, Aug 03, 2010 at 12:09:15PM -0700, Jim Busser wrote:
>> Larger vendors will often point to the yearly fees they have to pay to their
>> middleware vendors as the justification for the higher maintenance fees and
>> to some degree this is true.
Same here and I do think it makes sense.
> This, with FreeDiams, is not the case, however I can
> understand how companies which bring in revenues might spend
> extra time to improve their data sources.
The data sources can indeed be improved. Checking drug
status (on market etc), checking literature for
> What should be the thinking about allowing users to
> contribute interactions to FreeDiams, and of providing the
I tend to think that 99% of all users will not participate.
The rest are 50% crazy and 50% really sane. The trick is the
identify the latter. IMO there's no difference to meatspace
- building relationships.
GPG key ID E4071346 @ wwwkeys.pgp.net
E167 67FD A291 2BEA 73BD 4537 78B9 A9F9 E407 1346